Showing results (171-180 of 279) with videos related to

Sort By:
Pageof 28
American Journal of Hypertension|February 13, 2019
Plasma Renin Activity Is a Predictive Biomarker of Blood Pressure Response in European but not in African Americans With Uncomplicated HypertensionMai Mehanna, Zhiying Wang, Yan Gong, et al.
Science Advances|October 28, 2022
Identification and characterization of circulating immune complexes in IgA nephropathyYasuyuki Matsumoto, Rajindra P Aryal, Jamie Heimburg-Molinaro, et al.
Pharmacotherapy|October 15, 2013
PROX1 gene variant is associated with fasting glucose change after antihypertensive treatmentYan Gong, Caitrin W McDonough, Amber L Beitelshees, et al.
Physics in Medicine and Biology|October 27, 2016
Automated segmentation of liver and liver cysts from bounded abdominal MR images in patients with autosomal dominant polycystic kidney diseaseYoungwoo Kim, Sonu K Bae, Tianming Cheng, et al.
Kidney International|January 2, 2018
Baseline total kidney volume and the rate of kidney growth are associated with chronic kidney disease progression in Autosomal Dominant Polycystic Kidney DiseaseAlan S L Yu, Chengli Shen, Douglas P Landsittel, et al.
Plos One|January 18, 2013
Urinary proteomic biomarkers for diagnosis and risk stratification of autosomal dominant polycystic kidney disease: a multicentric studyAndreas D Kistler, Andreas L Serra, Justyna Siwy, et al.
Circulation. Cardiovascular Genetics|October 23, 2012
Hypertension susceptibility loci and blood pressure response to antihypertensives: results from the pharmacogenomic evaluation of antihypertensive responses studyYan Gong, Caitrin W McDonough, Zhiying Wang, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|August 4, 2016
Prognostic enrichment design in clinical trials for autosomal dominant polycystic kidney disease: the HALT-PKD clinical trialMaría V Irazabal, Kaleab Z Abebe, Kyongtae Ty Bae, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|December 19, 2022
Venglustat, a Novel Glucosylceramide Synthase Inhibitor, in Patients at Risk of Rapidly Progressing ADPKD: Primary Results of a Double-Blind, Placebo-Controlled, Phase 2/3 Randomized Clinical TrialRonald T Gansevoort, Ali Hariri, Pascal Minini, et al.
BMC Nephrology|December 29, 2018
Relationship between caffeine intake and autosomal dominant polycystic kidney disease progression: a retrospective analysis using the CRISP cohortKatelyn A McKenzie, Mirelle El Ters, Vicente E Torres, et al.
Pageof 28